Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 790

1.

Hemodynamic Responses and G Protection Afforded by Three Different Anti-G Systems.

Pollock RD, Firth RV, Storey JA, Phillips KE, Connolly DM, Green NDC, Stevenson AT.

Aerosp Med Hum Perform. 2019 Nov 1;90(11):925-933. doi: 10.3357/AMHP.4927.2019.

PMID:
31666153
2.

Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy".

Choy E, Ballman K, Chen J, Dickson MA, Chugh R, George S, Okuno S, Pollock R, Patel RM, Hoering A, Patel S.

Sarcoma. 2019 Aug 27;2019:7608743. doi: 10.1155/2019/7608743. eCollection 2019.

3.

Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.

Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH.

J Surg Res. 2019 Sep 5;245:577-586. doi: 10.1016/j.jss.2019.08.002. [Epub ahead of print]

PMID:
31494391
4.

Aircrew Conditioning Programme Impact on +Gz Tolerance.

Slungaard E, Pollock RD, Stevenson AT, Green NDC, Newham DJ, Harridge SDR.

Aerosp Med Hum Perform. 2019 Sep 1;90(9):764-773. doi: 10.3357/AMHP.5318.2019.

PMID:
31426891
5.

The incidence and outcome of chondral tumours as incidental findings on investigation of shoulder pathology.

Jassim SS, Hilton T, Saifuddin A, Pollock R.

Eur J Orthop Surg Traumatol. 2019 Aug 17. doi: 10.1007/s00590-019-02532-1. [Epub ahead of print]

PMID:
31422474
6.

MDM2 Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes.

Casadei L, Calore F, Braggio DA, Zewdu A, Deshmukh AA, Fadda P, Lopez G, Wabitsch M, Song C, Leight JL, Grignol VP, Lev D, Croce CM, Pollock RE.

Cancer Res. 2019 Oct 1;79(19):4911-4922. doi: 10.1158/0008-5472.CAN-19-0203. Epub 2019 Aug 6.

PMID:
31387924
7.

Long-term Cost-effectiveness of Insulin Degludec Versus Insulin Glargine U100 in the UK: Evidence from the Basal-bolus Subgroup of the DEVOTE Trial (DEVOTE 16).

Pollock RF, Valentine WJ, Marso SP, Andersen A, Gundgaard J, Hallén N, Tutkunkardas D, Magnuson EA, Buse JB; DEVOTE study group.

Appl Health Econ Health Policy. 2019 Oct;17(5):615-627. doi: 10.1007/s40258-019-00494-3.

8.

Targeted muscle reinnervation in oncologic amputees: Early experience of a novel institutional protocol.

Alexander JH, Jordan SW, West JM, Compston A, Fugitt J, Bowen JB, Dumanian GA, Pollock R, Mayerson JL, Scharschmidt TJ, Valerio IL.

J Surg Oncol. 2019 Sep;120(3):348-358. doi: 10.1002/jso.25586. Epub 2019 Jun 13.

PMID:
31197851
9.

Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.

Pollock RF, Muduma G.

Adv Ther. 2019 Aug;36(8):1821-1825. doi: 10.1007/s12325-019-00993-8. Epub 2019 Jun 1. No abstract available.

10.
11.

Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting.

Gæde P, Johansen P, Tikkanen CK, Pollock RF, Hunt B, Malkin SJP.

Diabetes Ther. 2019 Aug;10(4):1297-1317. doi: 10.1007/s13300-019-0630-6. Epub 2019 May 16. Erratum in: Diabetes Ther. 2019 May 31;:.

12.

Stanmore noninvasive extendible endoprosthesis in the treatment of bone sarcoma in the preadolescent.

Sambri A, Staals E, Medellin MR, Abudu A, Gikas P, Pollock R, Briggs TW, Donati DM, Manfrini M.

J Surg Oncol. 2019 Aug;120(2):176-182. doi: 10.1002/jso.25501. Epub 2019 May 15.

PMID:
31093984
13.

Synchronous recurrence of concurrent colon adenocarcinoma and dedifferentiated liposarcoma.

Jung EE, Heinemann FS, Egelston CA, Wang J, Pollock RE, Lee PP, Tseng WW.

BMJ Case Rep. 2019 May 13;12(5). pii: e228868. doi: 10.1136/bcr-2018-228868.

PMID:
31088817
14.

Anatomical Revelations in 1921 Kindled Operative Repair of the Orbit, Eyelids, and Periorbit over the Ensuing 100 Years: The Diuturnity of Ernest Whitnall (1876-1950) of Oxford, Montreal, and Bristol.

Pollock RA, Gossman MD.

Craniomaxillofac Trauma Reconstr. 2019 Jun;12(2):95-107. doi: 10.1055/s-0039-1677696. Epub 2019 Mar 1. Review.

PMID:
31073358
15.

Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.

Bill KLJ, Seligson ND, Hays JL, Awasthi A, Demoret B, Stets CW, Duggan MC, Bupathi M, Brock GN, Millis SZ, Shakya R, Timmers CD, Wakely PE Jr, Pollock RE, Chen JL.

Oncologist. 2019 Jul;24(7):989-996. doi: 10.1634/theoncologist.2019-0047. Epub 2019 Apr 24.

PMID:
31019022
16.

HPV infection and pre-term birth: a data-linkage study using Scottish Health Data.

Aldhous MC, Bhatia R, Pollock R, Vragkos D, Cuschieri K, Cubie HA, Norman JE, Stock SJ.

Wellcome Open Res. 2019 Mar 8;4:48. doi: 10.12688/wellcomeopenres.15140.1. eCollection 2019.

17.

Autophagy inhibition overcomes sorafenib resistance in S45F-mutated desmoid tumors.

Braggio D, Koller D, Jin F, Siva N, Zewdu A, Lopez G, Batte K, Casadei L, Welliver M, Strohecker AM, Lev D, Pollock RE.

Cancer. 2019 Aug 1;125(15):2693-2703. doi: 10.1002/cncr.32120. Epub 2019 Apr 12.

PMID:
30980399
19.

Short-term cost-utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9).

Pollock RF, Heller S, Pieber TR, Woo V, Gundgaard J, Hallén N, Luckevich M, Tutkunkardas D, Zinman B; DEVOTE Study Group.

Diabetes Obes Metab. 2019 Jul;21(7):1706-1714. doi: 10.1111/dom.13730. Epub 2019 Apr 14.

20.

A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA.

Johansen P, Hunt B, Iyer NN, Dang-Tan T, Pollock RF.

Adv Ther. 2019 May;36(5):1190-1199. doi: 10.1007/s12325-019-00915-8. Epub 2019 Mar 14. Erratum in: Adv Ther. 2019 Apr 12;:.

21.

Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis.

Pollock RA, Zaman L, Chandran V, Gladman DD.

PLoS One. 2019 Feb 19;14(2):e0212043. doi: 10.1371/journal.pone.0212043. eCollection 2019.

22.

Synovial sarcoma in an HIV-positive pregnant woman and review of literature.

Akhanoba F, Zill-E-Huma R, Pollock R, Edwards SJE.

BMJ Case Rep. 2019 Jan 29;12(1). pii: e227646. doi: 10.1136/bcr-2018-227646. Review.

PMID:
30700464
23.

A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment.

Pollock RF, Muduma G.

Expert Rev Hematol. 2019 Feb;12(2):129-136. doi: 10.1080/17474086.2019.1575202. Epub 2019 Feb 19.

PMID:
30689458
24.

Lower Body Acceleration and Muscular Responses to Rotational and Vertical Whole-Body Vibration at Different Frequencies and Amplitudes.

Zaidell LN, Pollock RD, James DC, Bowtell JL, Newham DJ, Sumners DP, Mileva KN.

Dose Response. 2019 Jan 6;17(1):1559325818819946. doi: 10.1177/1559325818819946. eCollection 2019 Jan-Mar.

25.

A cost-utility analysis of dulaglutide versus insulin glargine as third-line therapy for Type 2 diabetes in Canada.

Pollock RF, Norrbacka K, Cameron C, Mancillas-Adame L, Jeddi M.

J Comp Eff Res. 2019 Mar;8(4):229-240. doi: 10.2217/cer-2018-0073. Epub 2019 Jan 15.

26.

Multidisciplinary sarcoma care.

Pollock RE, Payne JE, Rogers AD, Smith SM, Iwenofu OH, Valerio IL, Zomerlei TA, Howard JH, Dornbos D 3rd, Galgano MA, Goulart C, Mendel E, Miller ED, Xu-Welliver M, Martin DD, Haglund KE, Bupathi M, Chen JL, Yeager ND.

Curr Probl Surg. 2018 Dec;55(12):517-580. doi: 10.1067/j.cpsurg.2018.10.006. Epub 2018 Nov 9. No abstract available.

PMID:
30526918
27.

SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy.

Choy E, Ballman K, Chen J, Dickson MA, Chugh R, George S, Okuno S, Pollock R, Patel RM, Hoering A, Patel S.

Sarcoma. 2018 Oct 24;2018:2068517. doi: 10.1155/2018/2068517. eCollection 2018. Erratum in: Sarcoma. 2019 Aug 27;2019:7608743.

28.

An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.

Pollock RF, Muduma G.

Adv Ther. 2018 Dec;35(12):2128-2137. doi: 10.1007/s12325-018-0827-5. Epub 2018 Nov 19.

PMID:
30456520
29.

Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.

Yu PY, Beal EW, Hughes TM, Suarez-Kelly LP, Shelby RD, Ethun CG, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH.

J Surg Res. 2018 Nov;231:248-256. doi: 10.1016/j.jss.2018.05.030. Epub 2018 Jun 23.

PMID:
30278937
30.

The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia.

Calore F, Londhe P, Fadda P, Nigita G, Casadei L, Marceca GP, Fassan M, Lovat F, Gasparini P, Rizzotto L, Zanesi N, Jackson D, Mehta S, Nana-Sinkam P, Sampath D, Pollock RE, Guttridge DC, Croce CM.

Cancer Res. 2018 Dec 1;78(23):6680-6690. doi: 10.1158/0008-5472.CAN-17-3878. Epub 2018 Sep 12.

31.

Surgical management of retroperitoneal sarcoma and opportunities for global collaboration.

Wang J, Grignol VP, Gronchi A, Luo CH, Pollock RE, Tseng WW.

Chin Clin Oncol. 2018 Aug;7(4):39. doi: 10.21037/cco.2018.07.05. Review.

32.

Multidisciplinary management of soft tissue sarcoma.

Tseng WW, Luo CH, Pollock RE.

Chin Clin Oncol. 2018 Aug;7(4):34. doi: 10.21037/cco.2018.08.09. No abstract available.

33.

A Case of Acute Iliocaval Thrombosis in the Setting of a Suprarenal Inferior Vena Cava Saccular Aneurysm.

Wu J, Strosberg DS, Pollock R, Haurani MJ.

Ann Vasc Surg. 2018 Nov;53:271.e7-271.e10. doi: 10.1016/j.avsg.2018.05.065. Epub 2018 Aug 6. Review.

PMID:
30092432
34.

miR-133a function in the pathogenesis of dedifferentiated liposarcoma.

Yu PY, Lopez G, Braggio D, Koller D, Bill KLJ, Prudner BC, Zewdu A, Chen JL, Iwenofu OH, Lev D, Strohecker AM, Fenger JM, Pollock RE, Guttridge DC.

Cancer Cell Int. 2018 Jun 26;18:89. doi: 10.1186/s12935-018-0583-2. eCollection 2018.

35.

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.

Palmer AJ, Si L, Tew M, Hua X, Willis MS, Asseburg C, McEwan P, Leal J, Gray A, Foos V, Lamotte M, Feenstra T, O'Connor PJ, Brandle M, Smolen HJ, Gahn JC, Valentine WJ, Pollock RF, Breeze P, Brennan A, Pollard D, Ye W, Herman WH, Isaman DJ, Kuo S, Laiteerapong N, Tran-Duy A, Clarke PM.

Value Health. 2018 Jun;21(6):724-731. doi: 10.1016/j.jval.2018.02.002. Epub 2018 Apr 9.

36.

Dedifferentiated Chondrosarcoma Demonstrating Osteosarcomatous Differentiation.

Dhinsa BS, DeLisa M, Pollock R, Flanagan AM, Whelan J, Gregory J.

Oncol Res Treat. 2018;41(7-8):456-460. doi: 10.1159/000487803. Epub 2018 Jun 15.

37.

Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival.

Subbiah V, Lamhamedi-Cherradi SE, Cuglievan B, Menegaz BA, Camacho P, Huh W, Ramamoorthy V, Anderson PM, Pollock RE, Lev DC, Qiao W, McAleer MF, Benjamin RS, Patel S, Herzog CE, Daw NC, Feig BW, Lazar AJ, Hayes-Jordan A, Ludwig JA.

Clin Cancer Res. 2018 Oct 1;24(19):4865-4873. doi: 10.1158/1078-0432.CCR-18-0202. Epub 2018 Jun 5.

38.

Second Primary Malignancies in Patients with Well-differentiated/Dedifferentiated Liposarcoma.

Jung E, Fiore M, Gronchi A, Grignol V, Pollock RE, Chong SS, Chopra S, Hamilton AS, Tseng WW.

Anticancer Res. 2018 Jun;38(6):3535-3542. doi: 10.21873/anticanres.12625.

PMID:
29848707
39.

Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach.

Pollock RF, Chubb B, Valentine WJ, Heller S.

Diabetes Metab Syndr Obes. 2018 May 16;11:217-226. doi: 10.2147/DMSO.S156739. eCollection 2018.

40.

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia.

Stein EM, Garcia-Manero G, Rizzieri DA, Tibes R, Berdeja JG, Savona MR, Jongen-Lavrenic M, Altman JK, Thomson B, Blakemore SJ, Daigle SR, Waters NJ, Suttle AB, Clawson A, Pollock R, Krivtsov A, Armstrong SA, DiMartino J, Hedrick E, Löwenberg B, Tallman MS.

Blood. 2018 Jun 14;131(24):2661-2669. doi: 10.1182/blood-2017-12-818948. Epub 2018 May 3.

41.

DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal-Bolus Regimens for Type 2 Diabetes in the UK.

Pollock RF, Valentine WJ, Marso SP, Gundgaard J, Hallén N, Hansen LL, Tutkunkardas D, Buse JB; DEVOTE Study Group.

Diabetes Ther. 2018 Jun;9(3):1217-1232. doi: 10.1007/s13300-018-0430-4. Epub 2018 Apr 30.

42.

An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland.

Pollock RF, Meckley LM.

Clinicoecon Outcomes Res. 2018 Apr 10;10:223-229. doi: 10.2147/CEOR.S155641. eCollection 2018.

43.

Correction to: Lane et al., Insulin degludec versus insulin glargine U100 for patients with type 1 or type 2 diabetes in the US: a budget impact analysis with rebate tables.

Lane W, Weatherall J, Gundgaard J, Pollock RF.

J Med Econ. 2018 May;21(5):542. doi: 10.1080/13696998.2018.1452510. Epub 2018 Mar 21. No abstract available.

PMID:
29560778
44.

Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States.

Wilkinson L, Hunt B, Johansen P, Iyer NN, Dang-Tan T, Pollock RF.

Diabetes Ther. 2018 Jun;9(3):951-961. doi: 10.1007/s13300-018-0402-8. Epub 2018 Mar 19.

45.

Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation.

Valentine WJ, Van Brunt K, Boye KS, Pollock RF.

Appl Health Econ Health Policy. 2018 Jun;16(3):357-366. doi: 10.1007/s40258-018-0379-5. Review.

PMID:
29525908
46.

Human physiological and metabolic responses to an attempted winter crossing of Antarctica: the effects of prolonged hypobaric hypoxia.

O'Brien KA, Pollock RD, Stroud M, Lambert RJ, Kumar A, Atkinson RA, Green DA, Anton-Solanas A, Edwards LM, Harridge SDR.

Physiol Rep. 2018 Mar;6(5). doi: 10.14814/phy2.13613.

47.

Major features of immunesenescence, including reduced thymic output, are ameliorated by high levels of physical activity in adulthood.

Duggal NA, Pollock RD, Lazarus NR, Harridge S, Lord JM.

Aging Cell. 2018 Apr;17(2). doi: 10.1111/acel.12750. Epub 2018 Mar 8.

48.

Properties of the vastus lateralis muscle in relation to age and physiological function in master cyclists aged 55-79 years.

Pollock RD, O'Brien KA, Daniels LJ, Nielsen KB, Rowlerson A, Duggal NA, Lazarus NR, Lord JM, Philp A, Harridge SDR.

Aging Cell. 2018 Apr;17(2). doi: 10.1111/acel.12735. Epub 2018 Mar 8.

49.

Fatty infiltration and muscle atrophy of the rotator cuff in stemless total shoulder arthroplasty: a prospective cohort study.

Sayed-Noor AS, Pollock R, Elhassan BT, Kadum B.

J Shoulder Elbow Surg. 2018 Jun;27(6):976-982. doi: 10.1016/j.jse.2017.12.021. Epub 2018 Feb 9.

PMID:
29433980
50.

Cardiorespiratory fitness not sedentary time or physical activity is associated with cardiometabolic risk in active older adults.

Pollock RD, Duggal NA, Lazarus NR, Lord JM, Harridge SDR.

Scand J Med Sci Sports. 2018 Jun;28(6):1653-1660. doi: 10.1111/sms.13071. Epub 2018 Feb 27.

PMID:
29427511

Supplemental Content

Loading ...
Support Center